Previous studies in EGFR-expressing NSCLC patients as well as several cell lines have shown that sensitivity to cetuximab and both EGFR-TKIs does not correlate with EGFR expression levels [32–34]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.